High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 26 Jan 2009 Planned number of patients changed from 90 to 160 as reported by ClinicalTrials.gov.
- 25 Jun 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
- 12 Oct 2007 New trial record.